Page 175 - Feline Cardiology

174 Section D: Cardiomyopathies

by two-dimensional echocardiography. Circulation 1983;68: and long-term management with low-dose aspirin in 24 cases. J
210–216. Vet Intern Med 2003;17:73–83.
Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH, et al. Assessment
hypertrophy in essential hypertension. A meta-analysis of ran- of mitral annulus velocity by Doppler tissue imaging in the evalu-
domized double-blind studies. JAMA 1996;275:1507–1513. ation of left ventricular diastolic function. J Am Coll Cardiol
Schober KE, Fuentes VL, Bonagura JD. Comparison between invasive 1997;30:474–480.
hemodynamic measurements and noninvasive assessment of left Soler R, Rodriguez E, Remuinan C, Bello MJ, Diaz A. Magnetic reso-
ventricular diastolic function by use of Doppler echocardiography nance imaging of primary cardiomyopathies. J Comput Assist
in healthy anesthetized cats. Am J Vet Res 2003;64:93–103. Tomogr 2003;27:724–734.
Schober KE, Maerz I. Assessment of left atrial appendage flow velocity Spaendonck-Zwarts KY, van den Berg MP, van Tintelen JP. DNA
and its relation to spontaneous echocardiographic contrast in 89 analysis in inherited cardiomyopathies: Current status and clinical
cats with myocardial disease. J Vet Intern Med 2006;20:120–130. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C.
relevance. Pacing Clin Electrophysiol 2008;31(Supp)1:S46–S49.
Cardiomyopathies electrocardiography and thoracic radiography in the assessment Spirito P, Maron BJ, Bonow RO, Epstein SE. Severe functional limita-
Schober KE, Maerz I, Ludewig E, Stern JA. Diagnostic accuracy of
Clinical course and prognosis of hypertrophic cardiomyopathy in
an outpatient population. N Engl J Med 1989;320:749–755.
of left atrial size in cats: comparison with transthoracic
2-dimensional echocardiography. J Vet Intern Med 2007;21:
709–718.
tion in patients with hypertrophic cardiomyopathy and only mild
Schuster P, Faerestrand S, Ohm OJ, Martens D, Torkildsen R, Oyehaug
localized left ventricular hypertrophy. J Am Coll Cardiol 1986;8:
537–544.
O. Feasibility of color Doppler tissue velocity imaging for assess-
ment of regional timing of left ventricular longitudinal movement. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of
Scand Cardiovasc J 2004;38:39–45. hypertrophic cardiomyopathy. N Engl J Med 1997;336:775–785.
Serres F, Pouchelon JL, Poujol L, Lefebvre HP, Trumel C, Daste T, et Stack RS, Ramage JE, Bauman RP, Rembert JC, Phillips HR, Kisslo JA.
al. Plasma N-terminal pro-B-type natriuretic peptide concentra- Validation of in vivo two-dimensional echocardiographic dimen-
tion helps to predict survival in dogs with symptomatic degenera- sion measurements using myocardial mass estimates in dogs. Am
tive mitral valve disease regardless of and in combination with the Heart J 1987;113:725–731.
initial clinical status at admission. J Vet Cardiol 2009;11:103–121. Stokol T, Brooks M, Rush JE, Rishniw M, Erb H, Rozanski E, et al.
Severino S, Caso P, Galderisi M, De Simone L, Petrocelli A, de Divitiis Hypercoagulability in cats with cardiomyopathy. J Vet Intern Med
O, et al. Use of pulsed Doppler tissue imaging to assess regional 2008;22:546–552.
left ventricular diastolic dysfunction in hypertrophic cardiomy- Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD.
opathy. Am J Cardiol 1998;82:1394–1398. Subendocardial motion in hypertrophic cardiomyopathy: assess-
Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, ment from long- and short-axis views by pulsed tissue Doppler
et al. Relation of tissue Doppler derived myocardial velocities to imaging. J Am Soc Echocardiogr 2000;13:108–115.
myocardial structure and beta-adrenergic receptor density in Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C.
humans. J Am Coll Cardiol 2000;36:891–896. Quantitative analysis of myocardial fibrosis in normals, hyperten-
Shapiro LM, Zezulka A. Hypertrophic cardiomyopathy: A common sive hearts, and hypertrophic cardiomyopathy. Br Heart J
disease with a good prognosis. Five year experience of a district 1986;55:575–581.
general hospital. Br Heart J 1983;50:530–533. Tandri H, Calkins H, Nasir K, Bomma C, Castillo E, Rutberg J, et al.
Sherrid MV. Pathophysiology and treatment of hypertrophic cardio- Magnetic resonance imaging findings in patients meeting task
myopathy. Prog Cardiovasc Dis 2006;49:123–151. force criteria for arrhythmogenic right ventricular dysplasia. J
Sherrid MV, Delia E, Dwyer E. Oral disopyramide therapy for obstruc- Cardiovasc Electrophysiol 2003;14:476–482.
tive hypertrophic cardiomyopathy. Am J Cardiol 1988;62: Taugner FM. Stimulation of the renin-angiotensin system in cats with
1085–1088. hypertrophic cardiomyopathy. J Comp Pathol 2001;125:122–129.
Sherrid MV, Gunsburg DZ, Moldenhauer S, Pearle G. Systolic anterior Tilley LP, Liu SK, Gilbertson SR, Wagner BM, Lord PF. Primary myo-
motion begins at low left ventricular outflow tract velocity in cardial disease in the cat. A model for human cardiomyopathy. Am
obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol J Pathol 1977;86:493–522.
2000;36:1344–1354. Towbin JA, Bowles NE. Molecular diagnosis of myocardial disease.
Sherrid MV, Pearle G, Gunsburg DZ. Mechanism of benefit of nega- Expert Rev Mol Diagn 2002;2:587–602.
tive inotropes in obstructive hypertrophic cardiomyopathy. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG,
Circulation 1998;97:41–47. Richards AM. Treatment of heart failure guided by plasma amino-
Simpson KE, Gunn-Moore DA, Shaw DJ, French AT, Dukes-McEwan terminal brain natriuretic peptide (N-BNP) concentrations.
J, Moran CM, et al. Pulsed-wave Doppler tissue imaging velocities Lancet 2000;355:1126–1130.
in normal geriatric cats and geriatric cats with primary or systemic Tsybouleva N, Zhang L, Chen S, Patel R, Lutucuta S, Nemoto S, et al.
diseases linked to specific cardiomyopathies in humans, and the Aldosterone, through novel signaling proteins, is a fundamental
influence of age and heart rate upon these velocities. J Feline Med molecular bridge between the genetic defect and the cardiac phe-
Surg 2009;11:293–304. notype of hypertrophic cardiomyopathy. Circulation 2004;109:
Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin 1284–1291.
North Am Small Anim Pract 2004;34:1105–1126. Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR,
Sisson DD, Knight DH, Helinski C, Fox PR, Bond BR, Harpster NK, Fraser AG. Differentiation between pathologic and physiologic left
et al. Plasma taurine concentrations and M-mode echocardio- ventricular hypertrophy by tissue Doppler assessment of long-axis
graphic measures in healthy cats and in cats with dilated cardio- function in patients with hypertrophic cardiomyopathy or sys-
myopathy. J Vet Intern Med 1991;5:232–238. temic hypertension and in athletes. Am J Cardiol 2001;88:53–58.
Smith SA, Tobias AH, Jacob KA, Fine DM, Grumbles PL. Arterial Wagner, T, et al. Comparison of auscultatory and echocardiography
thromboembolism in cats: Acute crisis in 127 cases (1992–2001) findings in healthy adult cats. J Vet Cardiol 2010;12:171–182.